Our research overview

Forging the future of age-related research

From cutting-edge methods to practical applications, we forge a future of proactive health solutions.

Starting with the creation of in-depth methods to assess the aging process, our team is working towards the ability to determine which interventions can effectively slow down the physical and molecular changes associated with aging. To achieve this, we use a combination of well-established measures like phenotypic age and functional assessments, as well as cutting-edge eyeAge models to gauge health status.

At Hoskinson Health and Wellness Clinic, we aim to apply these results into practical applications with patient care, including stem cell therapies, hyperbaric treatments, interventions to enhance cognitive function, and methods to improve metabolic health.

Current research studies:

GlyLo Supplementation in Post-Menopausal Women

Collaborators – Buck Institute for Research on Aging, CA and Wyoming Center on Aging, University of Wyoming, WY
This study is to investigate effect of a nutritional supplement (GlyLo) on weight loss and aging parameters. In addition, we are measuring the reduction of harmful compounds, such as advanced glycation end products.

Biofeedback in Children and Adolescents with ADHD

Study to examine the effects of a integrative intervention Healing Minds that includes Heart Math Biofeedback and Breathing Practices on ADHD severity and Heart Rate Variability in children and adolescents diagnosed with ADHD. The study also explores the effect of the intervention on the mental health of children like PTSD, anxiety and resilience.

Hyperbaric oxygen and Stem Cell Therapy in Adults with Long COVID-19

The study employs an innovative research methodology to address the aging-related debilitation resulting from long COVID-19. The ground breaking combination of stem cell and hyperbaric oxygen therapy represent a novel and unprecedented approach aimed at enhancing overall health and mitigating age-related issues associated with long COVID.